HSBC Holdings’s Novo Nordisk NVO Stock Holding History

HSBC Holdings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.8M	Buy	+100,000	New	+$4.3M	﹤0.01%	1227
2026 Q1	–	Sell	-80,000	Closed	-$4.09M	–	3127
2025 Q4	$4.09M	Buy	80,000 +71,500	+841%	+$3.66M	﹤0.01%	1289
2025 Q3	$472K	Sell	8,500 -10,000	-54%	-$585K	﹤0.01%	2134
2025 Q2	$1.28M	Hold	18,500	–	–	﹤0.01%	1679
2025 Q1	$1.28M	Sell	18,500 -131,500	-88%	-$10.9M	﹤0.01%	1645
2024 Q4	$12.9M	Buy	+150,000	New	+$16.2M	0.01%	853
2016 Q4	–	Sell	-2,000	Closed	-$42K	–	2762
2016 Q3	$42K	Buy	+2,000	New	+$49.6K	﹤0.01%	2020

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

HSBC Holdings's NVO Position: Q2 2026 in Review

HSBC Holdings reduced its Novo Nordisk (NVO) stake by 42% in Q2 2026, selling an estimated $16.1M and leaving 524,829 shares worth $25.2M. The position accounts for 0.01% of the portfolio, ranked #693.

HSBC Holdings first reported a position in NVO in Q3 2014 and has held it in 48 quarters since. The position peaked at $55M in Q2 2023. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

HSBC Holdings held 524,829 shares of Novo Nordisk worth $25.2M as of Q2 2026.
HSBC Holdings sold 374,975 Novo Nordisk shares in Q2 2026, an estimated $16.1M.
Novo Nordisk made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #693 holding.
HSBC Holdings first reported a position in Novo Nordisk in Q3 2014 and has held it in 48 quarters since.
HSBC Holdings's Novo Nordisk position peaked at $55M in Q2 2023.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.